Company Filing History:
Years Active: 2002-2005
Title: Innovations by Jane L Wang
Introduction
Jane L Wang is an accomplished inventor based in Wildwood, MO (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit cholesteryl ester transfer protein (CETP) activity. With a total of 2 patents, her work is pivotal in addressing coronary artery diseases.
Latest Patents
Jane's latest patents include:
1. **Substituted aromatic polycyclic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity** - This invention relates to substituted aromatic polycyclic tertiary-heteroalkylamine compounds that serve as inhibitors of CETP, along with methods for treating atherosclerosis and other coronary artery diseases.
2. **Method of using substituted N-benzyl-N-phenyl aminoalcohols for inhibiting cholesteryl ester transfer protein activity** - This patent focuses on the use of substituted aromatic polycyclic tertiary-heteroalkylamine compounds, specifically N-benzyl-N-phenyl aminoalcohols, as inhibitors of CETP and their application in treating coronary artery diseases.
Career Highlights
Jane L Wang is currently associated with G.D. Searle & Company, where she continues to innovate in the pharmaceutical sector. Her research has led to advancements in treatments for serious health conditions, showcasing her dedication to improving patient outcomes.
Collaborations
Throughout her career, Jane has collaborated with notable colleagues, including James A Sikorski and Richard C Durley. These partnerships have enhanced her research and contributed to the success of her inventions.
Conclusion
Jane L Wang is a prominent inventor whose work in developing CETP inhibitors is crucial for treating coronary artery diseases. Her contributions to the field of pharmaceuticals reflect her commitment to innovation and improving health outcomes.